Clinical Trials Logo

Clinical Trial Summary

To evaluate the pharmacokinetic (PK) characteristics and pharmacological effect of OPC-61815 in healthy Chinese Male subjects


Clinical Trial Description

To evaluate the pharmacokinetic (PK) characteristics of single and multiple intravenous administration of OPC-61815 in healthy Chinese subjects. To evaluate the safety of single and multiple intravenous administration of OPC-61815 in healthy Chinese subjects. To evaluate the pharmacological effect of single and multiple intravenous administration of OPC-61815 in healthy Chinese subjects. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05439148
Study type Interventional
Source Otsuka Beijing Research Institute
Contact
Status Completed
Phase Phase 1
Start date June 30, 2022
Completion date September 21, 2022

See also
  Status Clinical Trial Phase
Completed NCT02875080 - Evaluation Study of the Bioavailability of Brexpiprazole Orally Disintegrating Tablets in Healthy Male Subjects Phase 1
Completed NCT04182958 - A Phase I, Open-Label Trial to Assess the Absorption, Metabolism, and Excretion of (14C)-OPC-61815 in Healthy Male Japanese Subjects Phase 1
Completed NCT03902574 - Bioequivalence Study of Brexpiprazole Orally Disintegrating Tablets (ODT) 2mg Phase 1
Completed NCT02994394 - A Study of OPC-41061 Orally Disintegrating (OD) Tablets Using 2 Different Formulations and 2 Dosing Regimens in Healthy Adult Male Subjects Phase 1
Completed NCT04415645 - Absorption, Metabolism, Excretion, and Mass Balance Study of [14C]-VVZ-149 in Healthy Adult Male Subjects Phase 1
Completed NCT01423435 - Study to Compare Pharmacokinetic Profiles of TRK-100STP in Japanese, Chinese, and South Korean Non-elderly Healthy Adult Males Phase 1
Completed NCT01258699 - A Study Comparing the Pharmacokinetics of BK-C-0701 320mg, 480mg and Thiocacid HR Tab 600mg in Healthy Adult Male Subjects Phase 1